Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD
NCT00383370
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular Age Related Macular Degeneration
Interventions
DRUG:
VEGF Trap
BIOLOGICAL:
VEGF Trap
Sponsor
Regeneron Pharmaceuticals